Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
A phase II trial of alternating mXELOX/mXELIRI plus bevacizumab (BEV) as first-line treatment for metastatic colorectal cancer (mCRC). Early [18F]FDG PET/CT response evaluation after a single dose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results